ATBPF
Price
$0.22
Change
+$0.03 (+15.79%)
Updated
Apr 8 closing price
ZVRA
Price
$8.29
Change
-$0.20 (-2.36%)
Updated
Dec 18, 04:59 PM (EDT)
71 days until earnings call
Ad is loading...

ATBPF vs ZVRA

Header iconATBPF vs ZVRA Comparison
Open Charts ATBPF vs ZVRABanner chart's image
Antibe Therapeutics
Price$0.22
Change+$0.03 (+15.79%)
Volume$33.94K
CapitalizationN/A
Zevra Therapeutics
Price$8.29
Change-$0.20 (-2.36%)
Volume$7.77K
CapitalizationN/A
ATBPF vs ZVRA Comparison Chart
Loading...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATBPF vs. ZVRA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATBPF is a Buy and ZVRA is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ATBPF: $0.22 vs. ZVRA: $8.29)
Brand notoriety: ATBPF and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATBPF: 100% vs. ZVRA: 105%
Market capitalization -- ATBPF: $11.43M vs. ZVRA: $442.22M
ATBPF [@Biotechnology] is valued at $11.43M. ZVRA’s [@Biotechnology] market capitalization is $442.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATBPF’s FA Score shows that 0 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • ATBPF’s FA Score: 0 green, 5 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVRA is a better buy in the long-term than ATBPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZVRA’s TA Score shows that 3 TA indicator(s) are bullish.

  • ZVRA’s TA Score: 3 bullish, 5 bearish.

Price Growth

ATBPF (@Biotechnology) experienced а 0.00% price change this week, while ZVRA (@Biotechnology) price change was -6.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Reported Earning Dates

ZVRA is expected to report earnings on Feb 28, 2025.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZVRA($442M) has a higher market cap than ATBPF($11.4M). ZVRA YTD gains are higher at: 26.565 vs. ATBPF (-68.387).
ATBPFZVRAATBPF / ZVRA
Capitalization11.4M442M3%
EBITDAN/A-78.22M-
Gain YTD-68.38726.565-257%
P/E RatioN/AN/A-
RevenueN/A24.5M-
Total CashN/A89.4M-
Total DebtN/A59.9M-
FUNDAMENTALS RATINGS
ATBPF vs ZVRA: Fundamental Ratings
ATBPF
ZVRA
OUTLOOK RATING
1..100
4965
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
7638
P/E GROWTH RATING
1..100
6828
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATBPF's Valuation (38) in the null industry is somewhat better than the same rating for ZVRA (83). This means that ATBPF’s stock grew somewhat faster than ZVRA’s over the last 12 months.

ZVRA's Profit vs Risk Rating (95) in the null industry is in the same range as ATBPF (100). This means that ZVRA’s stock grew similarly to ATBPF’s over the last 12 months.

ATBPF's SMR Rating (97) in the null industry is in the same range as ZVRA (98). This means that ATBPF’s stock grew similarly to ZVRA’s over the last 12 months.

ZVRA's Price Growth Rating (38) in the null industry is somewhat better than the same rating for ATBPF (76). This means that ZVRA’s stock grew somewhat faster than ATBPF’s over the last 12 months.

ZVRA's P/E Growth Rating (28) in the null industry is somewhat better than the same rating for ATBPF (68). This means that ZVRA’s stock grew somewhat faster than ATBPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATBPFZVRA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HBSGX28.37N/A
N/A
Hartford Small Cap Growth HLS IB
TENWX11.00N/A
N/A
Nuveen Emerging Markets Eq Idx W
JHSGX29.80-1.00
-3.25%
JHancock U.S. Growth R4
CRMAX10.82-0.41
-3.65%
CRM Small/Mid Cap Value Inv
PMPSX39.16-2.93
-6.96%
ProFunds Precious Metals UltraSector Svc

ATBPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATBPF has been loosely correlated with IRON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATBPF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATBPF
1D Price
Change %
ATBPF100%
N/A
IRON - ATBPF
53%
Loosely correlated
-1.78%
KMSTF - ATBPF
52%
Loosely correlated
N/A
SRZN - ATBPF
47%
Loosely correlated
-4.80%
CDIO - ATBPF
25%
Poorly correlated
-24.11%
ZVRA - ATBPF
22%
Poorly correlated
+0.47%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with AXON. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
-2.24%
AXON - ZVRA
33%
Loosely correlated
-4.06%
GOSS - ZVRA
33%
Poorly correlated
-7.84%
VCYT - ZVRA
33%
Poorly correlated
-6.42%
PGEN - ZVRA
32%
Poorly correlated
+3.26%
CRNX - ZVRA
31%
Poorly correlated
-5.92%
More